Long-term results of treatment with bosentan in adult Eisenmenger’s syndrome patients with Down’s syndrome related to congenital heart disease

BACKGROUND: Patients with Down’s syndrome and shunt lesions are at high risk of developing pulmonary arterial hypertension (PAH) earlier than patients without Down’s syndrome. However, data on the efficacy of PAH-specific therapy in patients with Down’s syndrome are limited. The aim of this retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Crepaz, Roberto, Romeo, Cristina, Montanaro, Donato, De Santis, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848635/
https://www.ncbi.nlm.nih.gov/pubmed/24047157
http://dx.doi.org/10.1186/1471-2261-13-74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848635/
https://www.ncbi.nlm.nih.gov/pubmed/24047157
http://dx.doi.org/10.1186/1471-2261-13-74

Ejemplares similares